Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for a neglected heart disease?

NCT ID NCT04023227

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study compared two heart failure medicines in people whose heart damage was caused by Chagas disease. It tested if a newer drug (sacubitril/valsartan) was better than a standard one (enalapril) at preventing hospital stays and death from heart problems. The goal was to find a more effective treatment for this specific and serious condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    CABA, Buenos Aires, C1221ADC, Argentina

  • Novartis Investigative Site

    CABA, Buenos Aires, C1425BEI, Argentina

  • Novartis Investigative Site

    Ramos Mejía, Buenos Aires, B1704ETD, Argentina

  • Novartis Investigative Site

    San Martín, Buenos Aires, 1604, Argentina

  • Novartis Investigative Site

    Temperley, Buenos Aires, 1834, Argentina

  • Novartis Investigative Site

    Villa María, Córdoba Province, X5900JKA, Argentina

  • Novartis Investigative Site

    Salta, Salta Province, A4406BPF, Argentina

  • Novartis Investigative Site

    San Miguel de Tucumán, San Miguel de Tucuman, T4000ICL, Argentina

  • Novartis Investigative Site

    Rosario, Santa Fe Province, 2000, Argentina

  • Novartis Investigative Site

    Rosario, Santa Fe Province, S2000DIF, Argentina

  • Novartis Investigative Site

    San Miguel Tucuman, Tucumán Province, T4000IFL, Argentina

  • Novartis Investigative Site

    San Miguel Tucuman, Tucumán Province, T4000JCU, Argentina

  • Novartis Investigative Site

    Buenos Aires, C1155 AHD, Argentina

  • Novartis Investigative Site

    Corrientes, W3400CDS, Argentina

  • Novartis Investigative Site

    Córdoba, 5000, Argentina

  • Novartis Investigative Site

    Córdoba, X5003DCE, Argentina

  • Novartis Investigative Site

    Córdoba, X5004BAL, Argentina

  • Novartis Investigative Site

    Córdoba, X5006CBI, Argentina

  • Novartis Investigative Site

    Formosa, P3600, Argentina

  • Novartis Investigative Site

    Formosa, P3634XAR, Argentina

  • Novartis Investigative Site

    Mendoza, M5500CHC, Argentina

  • Novartis Investigative Site

    Santa Fe, S3000EOZ, Argentina

  • Novartis Investigative Site

    Santa Fe, S3000FWO, Argentina

  • Novartis Investigative Site

    Santiago del Estero, G4200AQK, Argentina

  • Novartis Investigative Site

    Fortaleza, Ceará, 60430 370, Brazil

  • Novartis Investigative Site

    Salvador, Estado de Bahia, 40050-410, Brazil

  • Novartis Investigative Site

    Salvador, Estado de Bahia, 40110060, Brazil

  • Novartis Investigative Site

    Salvador, Estado de Bahia, 40323-010, Brazil

  • Novartis Investigative Site

    Salvador, Estado de Bahia, 41253-190, Brazil

  • Novartis Investigative Site

    Brasila, Federal District, 70673623, Brazil

  • Novartis Investigative Site

    Brasília, Federal District, 70390-903, Brazil

  • Novartis Investigative Site

    Brasília, Federal District, 70710-100, Brazil

  • Novartis Investigative Site

    Goiânia, Goiás, 74223-060, Brazil

  • Novartis Investigative Site

    Goiânia, Goiás, 74223-130, Brazil

  • Novartis Investigative Site

    Goiânia, Goiás, 74605-020, Brazil

  • Novartis Investigative Site

    São Luís, Maranhão, 65020-070, Brazil

  • Novartis Investigative Site

    Belo Horizonte, Minas Gerais, 30130-100, Brazil

  • Novartis Investigative Site

    Belo Horizonte, Minas Gerais, 30140 062, Brazil

  • Novartis Investigative Site

    Belo Horizonte, Minas Gerais, 30150-270, Brazil

  • Novartis Investigative Site

    Montes Claros, Minas Gerais, 39401-001, Brazil

  • Novartis Investigative Site

    Passos, Minas Gerais, 37904-020, Brazil

  • Novartis Investigative Site

    Uberaba, Minas Gerais, 38025-440, Brazil

  • Novartis Investigative Site

    Uberlândia, Minas Gerais, 38400 500, Brazil

  • Novartis Investigative Site

    Uberlândia, Minas Gerais, 38400-328, Brazil

  • Novartis Investigative Site

    Londrina, Paraná, 86038-440, Brazil

  • Novartis Investigative Site

    Belém, Pará, 66087-660, Brazil

  • Novartis Investigative Site

    Recife, Pernambuco, 50100-060, Brazil

  • Novartis Investigative Site

    Teresina, Piauí, 64001-380, Brazil

  • Novartis Investigative Site

    Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil

  • Novartis Investigative Site

    Rio de Janeiro, Rio de Janeiro, 22240-006, Brazil

  • Novartis Investigative Site

    Natal, Rio Grande do Norte, 59020-035, Brazil

  • Novartis Investigative Site

    Ijuí, Rio Grande do Sul, 98700-000, Brazil

  • Novartis Investigative Site

    Botucatu, São Paulo, 3880-1001, Brazil

  • Novartis Investigative Site

    Bragança Paulista, São Paulo, 13183-091, Brazil

  • Novartis Investigative Site

    Campinas, São Paulo, 13020-431, Brazil

  • Novartis Investigative Site

    Campinas, São Paulo, 13060 080, Brazil

  • Novartis Investigative Site

    Campinas, São Paulo, 13060-904, Brazil

  • Novartis Investigative Site

    Indaiatuba, São Paulo, 13330-570, Brazil

  • Novartis Investigative Site

    Marília, São Paulo, 17515-000, Brazil

  • Novartis Investigative Site

    Ribeirão Preto, São Paulo, 14010-190, Brazil

  • Novartis Investigative Site

    Ribeirão Preto, São Paulo, 14048-900, Brazil

  • Novartis Investigative Site

    Santo André, São Paulo, 09080-001, Brazil

  • Novartis Investigative Site

    Sao Jose Rio Preto, São Paulo, 15090-000, Brazil

  • Novartis Investigative Site

    São Paulo, São Paulo, 04012 909, Brazil

  • Novartis Investigative Site

    São Paulo, São Paulo, 05403-000, Brazil

  • Novartis Investigative Site

    Tatuí, São Paulo, 18270-170, Brazil

  • Novartis Investigative Site

    Votuporanga, São Paulo, 15500 003, Brazil

  • Novartis Investigative Site

    São Paulo, 05403-000, Brazil

  • Novartis Investigative Site

    São Paulo, 15015-210, Brazil

  • Novartis Investigative Site

    Bogota, Cundinamarca, 110121, Colombia

  • Novartis Investigative Site

    Santa Marta, Magdalena Department, 30360, Colombia

  • Novartis Investigative Site

    San Gil, Santander Department, 684031, Colombia

  • Novartis Investigative Site

    Bogota DC, 110111, Colombia

  • Novartis Investigative Site

    Florida Blanca, 681001, Colombia

  • Novartis Investigative Site

    Floridablanca, 681004, Colombia

  • Novartis Investigative Site

    Mérida, Yucatán, 97000, Mexico

  • Novartis Investigative Site

    Ciudad de, 14080, Mexico

  • Novartis Investigative Site

    Oaxaca City, 68000, Mexico

  • Novartis Investigative Site

    Xalapa, 91193, Mexico

Conditions

Explore the condition pages connected to this study.

CHAGAS DISEASE HEART FAILURE